We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Non-standard Finance Plc | LSE:NSF | London | Ordinary Share | GB00BRJ6JV17 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.04 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
27/4/2020 16:17 | Someone is chasing these, the bid keeps getting moved up | 32campomar | |
27/4/2020 14:38 | Its starting to trade like a "real" share, tight spread and everything 0.39, thats a first for a long while | arai | |
27/4/2020 10:40 | Excellent and positive article in the Times. Thanks for posting | dodger777 | |
27/4/2020 10:12 | thanks speedsgh. gla | andyview | |
27/4/2020 10:10 | Yes there's not a lot left to say. When serious talk of lifting the lockdown measures start gaining traction, this will move the share price further north. Also, FY results will help stabilise sentiment soon too. I think we will see 20p soon, then a slow march to 30p, then within 6-18 months a slow and steady climb to 50p. Beyond that 75p is on the cards. £20m net profit on a PE of 10 gives a share price of 63p (ish), a PE of 15 would gives a share price of 94p, this is all very much achievable in 3-5 yrs imo. | grapevinefriend | |
27/4/2020 09:59 | Not really a lot to say is there until the next update. Last was good and should support a continued re-rate here as still looking very oversold. Fingers crossed the next is good and then we will really start to recover towards fair value. P.s. I like a quiet board, it's when the hoards arrive it's generally time to sell!! | otemple3 | |
27/4/2020 08:56 | Onwards & upwards,make mine a double at 16p for starters! Steady progress but quiet on here, has everyone already sold out, or still in bed? Lol Some great returns on some other of these bio covid stocks, incl Scancell (SCLP) involved in developing a long term vaccine. Certainly some under valued stocks about incl many blue chip multi nations to tuck away. | ny boy | |
26/4/2020 23:22 | @32campomar...yep I think time will put value. Amigo has a few demons to get rid of before it can get back to something like true value. Tomorrow will be interesting. | telbap | |
24/4/2020 16:28 | Bought the Times today & it's quite a compelling Article to buy NSF. All shares have their risk but the article illustrates just how underpriced this is. Not surprised it's generated a lot of buying interest. | 32campomar | |
24/4/2020 16:20 | @Galaxy, I thought the same with amigo. Now 50% down I realise that sometimes value is not always the key metric, sentiment is.A lot of snowflake anti sentiment for what are perceived as "payday" lenders. Before you all start, I know this is not a payday special, but are we seeing a small rally before the next fall off ? Certainly there is value here. Small punt for me I think. | telbap | |
24/4/2020 13:47 | 14.05p - Some great bargains to be had in this stock market - | tomboyb | |
24/4/2020 13:38 | Lovely initial move with the stock up 27% and continuing to push regular intraday highs. The chart has turned up now and likely with initial eyes on the 50 day moving average around that 18p mark. If you look at the wider market and the 50% bear mark loss retracement phenomenon, there is an argument for the stock to test that 20p mark with the longer term downtrend a further 20% higher so take your pick folks! I'd love to be able to sell around 20p. Always a short term in and out this one. | sphere25 | |
24/4/2020 12:15 | NY B already have exposure to some undervalued Pharma's such as HEMO and NFX so don't need anymore. NSF is the one to concentrate on: | galaxy enforcer | |
24/4/2020 11:45 | GE, long term hold for me here meanwhile talking of COVID-19 , I am very keen on (SCLP) to play the long game in the COVID vaccine field, a spec punt for me whilst it’s still sub 10p dyor as usual. | ny boy | |
24/4/2020 11:32 | should see 16p today imo | itsnotmeitsy0u | |
24/4/2020 11:08 | Sometimes you need to slap people in the face with a Kipper (or copy of The Times) to wake them up to the potential value of a share. Yes many people have sat and done their research into #NSF and can see the massive potential and opportunity locked up here. The unfortunate scenario of Covid 19 has presented buying opportunity which may never be seen again. | galaxy enforcer | |
24/4/2020 11:04 | The article picked up pretty much what everyone said on here yesterday.. it's summary of robust balance sheet, strong growth potential particularly in a recession and the shares are very cheap - Buy. | tole | |
24/4/2020 10:45 | Massive volume and the size of those trades | sbb1x | |
24/4/2020 10:30 | It's a good article, am not always convinced by Tempus but this write up seems fair to me (as a holder!) | otemple3 | |
24/4/2020 10:29 | Maybe the seller has cleared? He's been there for ages at some point he'll be done and this will be re-rated | 32campomar | |
24/4/2020 10:23 | It is climbing now - | tomboyb | |
24/4/2020 10:20 | Stock looks interesting for the first time in a while. | sphere25 | |
24/4/2020 10:00 | Thanks! I'll buy one later. Always thought people have underestimated how valuable lenders like this will be in bad times. I recall Woodford offloading at 40p when the fund was desperate to raise cash and that was at a huge discount to the share price at the time. Just shows how cheap this has become. | 32campomar | |
24/4/2020 09:49 | The rest of the article is subscription only. Still the above is enough really to get the picture, a slow grind North, with occasional pull backs as some punters cash in along the way. Best strategy buy and hold for medium/longer term post corona | ny boy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions